The Ministry mentioned that safety is enhanced if the second dose of Covishield is run between 6-8 weeks, however not later than stipulated interval of 8 weeks preserving the present scientific proof in view.
The Centre has written to states and union territories to extend the interval between two doses of Covishield primarily based on NTAGI and NEGVAC Suggestion.
Nonetheless, for the indigenously produced Covid-19 vaccine, Covaxin, it determined to proceed with the present interval of 4-6 weeks.
In view of the rising scientific proof, the interval between two doses of Covishield, was revisited by Nationwide Technical Advisory Group on Immunization (NTAGI) and Nationwide Knowledgeable Group on Vaccine Administration for Covid-19 (NEGVAC) in its twentieth assembly.
Throughout this assembly the advice has been revised to supply the second dose of Covishield at 4-8 weeks’ interval after the first dose, as a substitute of earlier practiced interval of 4-6 weeks.
“This resolution of revised time interval between two doses is relevant ONLY to Covishield and NOT to Covaxin vaccine,” the Well being Ministry mentioned.
In a letter written by the Union Well being Secretary Rajesh Bhushan to the Chief Secretaries of States and UTs as we speak, he has famous that the Ministry has accepted the suggestions of NTAGI and NEGVAC and has thereafter suggested the states and UTs to make sure the administration of second dose of Covishield to beneficiaries inside this stipulated time interval of 4-8 weeks after 1st dose.
Union Well being Secretary has urged the States and UTs to instruct the involved officers accordingly to undertake needed steps to extensively disseminate the message of revised dosing interval amongst programme managers, vaccinators and recipients of Covishield vaccine and guarantee adherence of the revised dosing interval.